Jagsonpal Pharmaceuticals Ltd 2023 Annual Report with Sustainability Disclosures
Company: Jagsonpal Pharmaceuticals Ltd
Sector: Manufacturing
Country: India
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 72
The report presents FY2023 as a transformational year, with revenue from operations of ₹2,367.14 million and operational EBITDA of ₹433.7 million. Its standalone sustainability disclosures highlight CSR work focused on women's health, menstrual hygiene, and sanitation infrastructure, including public toilets. The report identifies 940 employees, women representing 33% of the six-member Board, and no workplace fatalities. Environmental disclosures state that Scope 1 and Scope 2 emissions are not applicable, consistent with the company's statement that it does not operate a manufacturing facility.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.